Orphan Drug

From Anvita Health Wiki

Contents 1 More Specific Terms 2 Introduction 3 More General Terms 4 References

More Specific Terms

• carglumic acid (Carbaglu)

Introduction

• In the U.S., the Orphan Drug Designation gives the manufacturer a 7 year market exclusivity once the drug goes to market.

• In Europe, the designation - termed Orphan Medicinal Product - typically allows for 10-year market exclusivity upon commercialization in the 15-member states of the European Union.

More General Terms

• pharmaceutical agent

References

[1]

orphan drug